Local
National
Date Range: -

COVID-19: Novavax vaccine shows 89% efficacy in UK trials

29th January 2021

It has been announced that the NIHR supported Novavax COVID-19 vaccine trial, which recruited in Yorkshire and Humber, has been shown to be 89.3% effective.

The vaccine will need to be reviewed by regulators before it can be used.

You can read more about the Novavax trial, which recruited in Bradford and Leeds as well as nationally, on the NIHR Yorkshire and Humber website: 

local.nihr.ac.uk/news/nihr-supported-studies-find-novavax-covid-19-vaccine-trialled-in-yorkshire-and-humber-is-893-effective/26740

New COVID and Me Vaccine videos released

14th December 2020

The NIHR has commissioned COVID and Me - Vaccines as part of an ongoing series hoping to support all communities to understand the importance of vaccine research. These short dramas embrace inclusivity and aim to support people to be able to make informed choices about vaccinations and vaccine research. 

You can find these on the Be Part of Research website:  

https://bepartofresearch.nihr.ac.uk/covid-and-me-vaccines/

Be Part of COVID-19 Vaccine Research

05th November 2020

NHS researchers in Yorkshire and Humber are working together to help find a vaccine for COVID-19. We are recruiting now for the next stage of clinical trials to help find a vaccine.

Alongside local partners, Leeds Teaching Hospitals NHS Trust has created a new video to share information about this:

To sign up visit: https://nhs.uk/ResearchContact

Yorkshire residents urged to take part in community Coronavirus trial

22nd October 2020

Our local NIHR Clinical Research Network advises:

"Following a significant rise in the number of cases across parts of Yorkshire, residents are being urged to sign up and take part in a national priority COVID-19 clinical trial from the comfort of their own homes."

Read more about the PRINCIPLE trial here:

https://local.nihr.ac.uk/news/yorkshire-residents-urged-to-take-part-in-community-coronavirus-trial/25952

Local update on the PRINCIPLE trial

16th October 2020

As shared in the Telegraph & Argus: "A leading Bradford pharmacist is carrying out ground-breaking work with the GP practices across the city to recruit people to join a clinical trial that uses two antibiotic drugs to treat COVID-19."

Read more: 

https://www.thetelegraphandargus.co.uk/news/18797736.ground-breaking-work-bradford-key-covid-treatment-trial/


New review into use of health data for research and analysis

10th February 2021

The review will focus on the more efficient and safe use of health data for research and analysis for the benefit of patients and the healthcare sector.

Read more online: https://www.gov.uk/government/news/new-review-into-use-of-health-data-for-research-and-analysis

COVID-19: Novavax vaccine shows 89% efficacy in UK trials

29th January 2021

It has been announced that the Novavax vaccine has shown 89% efficacy in UK trials. The vaccine will need to be reviewed by regulators before it can be used.

You can read more about the Novavax trial, which recruited in Bradford and Leeds as well as nationally, on the BBC website:

www.bbc.co.uk/news/uk-55850352

NIHR issues final update on implementation of the Restart Framework

28th January 2021

You can read the current advice on the delivery of non-COVID research in the latest restarting research update.

You can find this update on the NIHR website: 

www.nihr.ac.uk/news/nihr-issues-final-update-on-implementation-of-the-restart-framework/26717

PRINCIPLE study update

25th January 2021

The NIHR-supported PRINCIPLE study has found no beneficial effect from the antibiotics azithromycin and doxycycline in COVID-19 patients being treated at home.

You can read more about this on the NIHR website:

https://www.nihr.ac.uk/news/principle-trial-finds-no-benefit-for-antibiotics-azithromycin-and-doxycycline-for-covid-19-patients/26680

Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator

08th January 2021

The Moderna COVID-19 vaccine has today been given regulatory approval for supply by the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more: https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator